176 related articles for article (PubMed ID: 7820955)
1. Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.
Maiorana A; Cesinaro AM; Fano RA; Collina G
Clin Exp Metastasis; 1995 Jan; 13(1):43-8. PubMed ID: 7820955
[TBL] [Abstract][Full Text] [Related]
2. MHC class I and II antigens on gastric carcinomas and autologous mucosa.
Ferron A; Perez-Ayala M; Concha A; Cabrera T; Redondo M; Oliva MR; Ruiz-Cabello F; Garrido F
J Immunogenet; 1989; 16(4-5):413-23. PubMed ID: 2639912
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
4. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
[TBL] [Abstract][Full Text] [Related]
5. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
6. Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases.
Lazzaro B; Anderson AE; Kajdacsy-Balla A; Hessner MJ
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):234-41. PubMed ID: 11556751
[TBL] [Abstract][Full Text] [Related]
7. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
[TBL] [Abstract][Full Text] [Related]
8. Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors.
Koretz K; Moldenhauer G; Majdic O; Möller P
Int J Cancer; 1989 Nov; 44(5):816-22. PubMed ID: 2583862
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
Möller P; Mattfeldt T; Gross C; Schlosshauer P; Koch A; Koretz K; Moldenhauer G; Kaufmann M; Otto HF
Am J Pathol; 1989 Jul; 135(1):73-83. PubMed ID: 2549795
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
D'Alessandro G; Zardawi I; Grace J; McCarthy WH; Hersey P
Pathology; 1987 Oct; 19(4):339-46. PubMed ID: 3328139
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of HLA class I antigens in breast cancer: association with prognosis.
Gudmundsdóttir I; Gunnlaugur Jónasson J; Sigurdsson H; Olafsdóttir K; Tryggvadóttir L; Ogmundsdóttir HM
Int J Cancer; 2000 Nov; 89(6):500-5. PubMed ID: 11102894
[TBL] [Abstract][Full Text] [Related]
13. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
[TBL] [Abstract][Full Text] [Related]
15. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
16. HLA class II sublocus expression in benign and malignant breast epithelium.
Zuk JA; Walker RA
J Pathol; 1988 Aug; 155(4):301-9. PubMed ID: 2459333
[TBL] [Abstract][Full Text] [Related]
17. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
18. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
Degener T; Momburg F; Möller P
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
[TBL] [Abstract][Full Text] [Related]
20. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
